Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis takes a step back from marketing Pear prescription digital therapeutics
Biopharma Dive
Wed, 10/16/19 - 06:57 pm
Tags:
Novartis, Sandoz, Pear Therapeutics, digital therapeutics, opioid abuse
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Yahoo/Benzinga
Mon, 10/14/19 - 09:43 am
Tags:
JNJ, Flexion Therapeutics, Novartis, Amgen, Clearside Biomedical, Alexion, Assertio Therapeutics, Aldeyra Therapeutics, Lineage Therapeutics, IMMUTEP, Marinus Pharma
Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity
BioSpace
Mon, 10/14/19 - 09:30 am
Tags:
Genentech, Pfizer, Merck, Amgen, Novartis
Novartis' ligelizumab outperforms Roche's Xolair in chronic urticaria clearance
Pharmafile
Wed, 10/9/19 - 11:10 pm
Tags:
Novartis, clinical trials, ligelizumab, Roche, Xolair, chronic urticaria
Eylea casts a shadow over Novartis' latest approval
Biopharma Dive
Wed, 10/9/19 - 11:04 pm
Tags:
Novartis, Beovu, wet age-related macular degeneration, Regeneron, Eylea
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
Tags:
M&A, Lundbeck, Alder Biopharmaceuticals, Gilead Sciences, Galapagos, Vertex Pharmaceuticals, Semma, Swedish Orphan Biovitrum, Dova Pharmaceuticals, Novartis, IFM
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Pharmaforum
Tue, 10/8/19 - 09:27 am
Tags:
Novartis, brolucizumab, Bayer, Eylea, wet age-related macular degeneration, FDA
Recent Job Cuts in the Biopharma Industry
BioSpace
Mon, 10/7/19 - 11:29 pm
Tags:
Tocagen, Sanofi, Amneal, Daiichi Sankyo, Integra Life Sciences, Aclaris, Bayer, Novartis, Illumina, Merck, Roche Molecular Systems, Prometheus Labs, layoffs
Novartis' latest Zolgensma data bode well for use in older patients
Fierce Pharma
Mon, 10/7/19 - 12:13 pm
Tags:
Novartis, Zolgensma, SMA, FDA, spinal muscular atrophy
It May Be Time For Standard Breast Cancer Treatment To Change
Forbes
Sun, 10/6/19 - 12:44 pm
Tags:
breast cancer, HER2-negative breast cancer, Novartis, ribociclib
A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
Investors Business Daily
Sat, 10/5/19 - 02:17 pm
Tags:
Coherus Biosciences, Novartis, Udenyca, Neulasta, biosmilars
Novartis stacks more positive PhIII data on Cosentyx franchise — eyeing approval in non-radiographic axial spondyloarthritis
Endpoints
Wed, 10/2/19 - 10:54 am
Tags:
Novartis, Cosentyx, axial spondyloarthritis
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Tags:
Bausch Health, Novartis, Sandoz, Xifaxan, patents
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Globe Newswire
Tue, 10/1/19 - 11:11 am
Tags:
Novartis, Microsoft, artificial intelligence, innovation, drug development
ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win
Fierce Pharma
Mon, 09/30/19 - 10:38 am
Tags:
Chi-Med, surufatinib, Pfizer, Sutent, Novartis, Afinitor, Lutathera, neuroendocrine tumors. ESMO
Novartis announces positive results from asthma combinations
Pharmaforum
Mon, 09/30/19 - 10:32 am
Tags:
Novartis, asthma, QMF149, QVM149, clinical trials
Blow to Novartis as NICE rejects migraine drug Aimovig again
Pharmaforum
Thu, 09/26/19 - 10:54 am
Tags:
Novartis, Aimovig, migraines, NICE
GlaxoSmithKline halts generic Zantac supply as global threat gains steam
Fierce Pharma
Thu, 09/26/19 - 10:50 am
Tags:
Novartis, GSK, generics, OTC, Zantac, product recalls
Novartis to put AveXis into protective custody after data manipulation scandal
Fierce Pharma
Tue, 09/24/19 - 10:17 pm
Tags:
Novartis, AveXis, Zolgensma
Novartis in political row after denying Belgian toddler compassionate access to gene therapy
Pharmaforum
Tue, 09/24/19 - 10:01 am
Tags:
Novartis, Zolgensma, SMA, compassionate use guidelines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.